CLINICAL_TRIALS
trial_result
· 2021-09-01
Clinical Trial Update: Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis [Phase 2]
Summary
Phase 2 clinical trial update on safety and tolerability of high-dose biotin in patients with amyotrophic lateral sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American University of Beirut Medical Center | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED